Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
4(66.7%)
Phase 2
1(16.7%)
Phase 3
1(16.7%)
6Total
N/A(4)
Phase 2(1)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT07114094Not ApplicableRecruiting

Development, Validation and Evaluation of a Deprescribing Tool

Role: collaborator

NCT03388944Not ApplicableCompleted

PCT Guided Stopping of Antibiotic Therapy in Children With Sepsis

Role: collaborator

NCT03235388Not ApplicableCompleted

The Trauma Audit Filters Trial

Role: collaborator

NCT03280147Phase 3Completed

7 Days Versus 14 Days of Antibiotics for Neonatal Sepsis

Role: collaborator

NCT02835157Not ApplicableCompleted

Balanced Crystalloid vs. Saline in Children With Septic Shock

Role: collaborator

NCT02774044Phase 2Unknown

Efficacy and Safety of Goat Lung Surfactant for the Treatment of Respiratory Distress Syndrome in Preterm Neonates

Role: collaborator

All 6 trials loaded